300869 康泰医学
2026/09 - 九个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-3.363-1.360-3.9938.34410.469
总资产报酬率 ROA (%)-2.144-0.889-2.6244.7746.017
投入资产回报率 ROIC (%)-2.183-0.903-2.6824.9306.265

边际利润分析
销售毛利率 (%)46.26548.04749.35057.58247.477
营业利润率 (%)-17.004-5.627-14.07925.00130.792
息税前利润/营业总收入 (%)-7.016-4.878-19.21720.78923.748
净利润/营业总收入 (%)-16.193-5.219-16.23622.19427.552

收益指标分析
经营活动净收益/利润总额(%)69.320104.163-16.42195.64173.118
价值变动净收益/利润总额(%)-18.850-68.818-32.6277.24924.884
营业外收支净额/利润总额(%)-1.7232.0578.577-0.3270.054

偿债能力分析
流动比率 (X)16.9668.38614.2545.3972.300
速动比率 (X)15.2007.56412.2334.3901.913
资产负债率 (%)34.90237.45831.85136.33848.341
带息债务/全部投入资本 (%)33.18736.20130.23434.34045.633
股东权益/带息债务 (%)200.383175.284229.547190.122117.616
股东权益/负债合计 (%)186.519166.963213.963175.196106.864
利息保障倍数 (X)-0.723-5.6275.033-5.032-3.363

营运能力分析
应收账款周转天数 (天)37.18336.94032.21148.34857.368
存货周转天数 (天)322.366371.563544.801507.615408.550